Drugs / Human Umbilical Cord Mesenchymal Stem Cells Injection
Human Umbilical Cord Mesenchymal Stem Cells Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07628933 | Jun 2026 → Mar 2028 expected | ischemic stroke | BOE Technology Group Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Umbilical Cord Mesenchymal Stem Cells Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07628933 ↗ |
| Modality | Cell therapy | “human umbilical cord-derived mesenchymal stromal cell injection” NCT07628933 ↗ |
| Route | Intravenous | “Single intravenous infusion” NCT07628933 ↗ |